Eli Lilly's Cymbalta approved for fibromyalgia

Eli Lilly and Co. announced Monday that the FDA has cleared the use of the antidepressant Cymbalta to treat fibromyalgia, a chronic illness characterized by extensive body pain, tenderness and fatigue. The expanded approval puts Cymbalta in competition with Pfizer's Lyrica, the first fibromyalgia medication to win FDA approval.

View Full Article in:

Indianapolis Star (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Economics & Reimbursement Manager - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA